Published on LinkedIn (via Spencer Knight) LB Pharmaceuticals completed the largest biotech IPO of 2025 to date, raising $285M to advance...

Published on LinkedIn (via Spencer Knight) Novartis has announced its $1.4 billion acquisition of Tourmaline Bio, a New York–based...

Published by Alliance for Regenerative Medicine The cell and gene therapy sector is rapidly expanding, with two blockbuster products...

Published on: See Hua Daily News (诗华日报) Sarawak Central Hospital has successfully performed the state’s first stem cell transplant,...

Published on: LinkedIn (Spencer Knight) The European Commission has approved TEVIMBRA (tislelizumab) from BeOne Medicines, the first PD-1...

Published on: LinkedIn (Spencer Knight) Scientists at Karolinska Institutet have reported a breakthrough gene therapy that restored...

Published on: LinkedIn (Spencer Knight) The FDA has approved Novartis’ Leqvio (inclisiran) as the first siRNA drug to lower LDL-C without...

Published on: ScienceAlert For the first time, a type 1 diabetes patient has begun producing insulin after receiving gene-edited islet...

Published on: LinkedIn (Spencer Knight) In just five days, two breakthrough approvals have reshaped treatment for metabolic...

Published on: LinkedIn (Spencer Knight) The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval...

Published on: Autolus Therapeutics The European Commission has granted marketing authorization for AUCATZYL (obecabtagene autoleucel) to...

Published on: Precigen Investors The U.S. FDA has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first therapy for...

Published on: Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal...

Published on: Cytotherapy CAR T-cell therapy has transformed outcomes for aggressive B-cell Non-Hodgkin lymphoma, yet many eligible...

Published on: Forbes A clinical trial by Vertex Pharmaceuticals has shown that lab-grown stem cell–derived islet cells can restore...

Published on: Multiple Sclerosis News Today A U.S. trial has treated the first multiple sclerosis (MS) patient with azercabtagene...

Published on: LinkedIn (Spencer Knight) A groundbreaking case in glioblastoma treatment has emerged from a U.S. clinical trial. Pamela...

Published on LinkedIn via Spencer Knight The FDA has given accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) for...

Published by UMC Utrecht In the PASSIoN safety study at UMC Utrecht, ten newborns with perinatal stroke received a single dose of...

Published in The Japan Times Sumitomo Pharma has applied for regulatory approval in Japan to market a cell therapy that transplants...